G. E. Francis

2.9k total citations
88 papers, 2.2k citations indexed

About

G. E. Francis is a scholar working on Molecular Biology, Hematology and Immunology. According to data from OpenAlex, G. E. Francis has authored 88 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 28 papers in Hematology and 23 papers in Immunology. Recurrent topics in G. E. Francis's work include Hematopoietic Stem Cell Transplantation (15 papers), Acute Myeloid Leukemia Research (15 papers) and Neutropenia and Cancer Infections (10 papers). G. E. Francis is often cited by papers focused on Hematopoietic Stem Cell Transplantation (15 papers), Acute Myeloid Leukemia Research (15 papers) and Neutropenia and Cancer Infections (10 papers). G. E. Francis collaborates with scholars based in United Kingdom, United States and Netherlands. G. E. Francis's co-authors include Cristina Delgado, Derek Fisher, J. J. Berney, Alan E. Smith, Samuel C. Wadsworth, Catherine R. O’Riordan, A. V. Hoffbrand, George Janossy, Sylvia Granger and A. Victor Hoffbrand and has published in prestigious journals such as Nature, The Lancet and The Journal of Experimental Medicine.

In The Last Decade

G. E. Francis

86 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. E. Francis United Kingdom 23 1.1k 561 498 408 336 88 2.2k
Janice M. Davis United States 21 639 0.6× 234 0.4× 737 1.5× 452 1.1× 397 1.2× 41 1.9k
M. Laurie Phillips United States 21 1.7k 1.6× 202 0.4× 366 0.7× 224 0.5× 1.1k 3.3× 47 3.3k
Glenn M. Swartz United States 21 975 0.9× 245 0.4× 175 0.4× 333 0.8× 351 1.0× 40 2.1k
Olivier Bertrand France 24 667 0.6× 152 0.3× 384 0.8× 113 0.3× 303 0.9× 87 2.3k
Shinji Yoshitake Japan 21 1.1k 1.1× 259 0.5× 614 1.2× 150 0.4× 248 0.7× 71 2.5k
Srikumar M. Raja United States 27 1.3k 1.2× 154 0.3× 313 0.6× 359 0.9× 684 2.0× 37 2.4k
K.C. Ingham United States 23 1.0k 1.0× 149 0.3× 233 0.5× 145 0.4× 162 0.5× 42 2.1k
John M. Maraganore United States 32 2.4k 2.2× 976 1.7× 1.7k 3.5× 307 0.8× 330 1.0× 55 6.0k
Don L. Siegel United States 34 1.0k 1.0× 339 0.6× 904 1.8× 742 1.8× 607 1.8× 107 3.4k
Éric Robinet France 23 323 0.3× 333 0.6× 303 0.6× 427 1.0× 582 1.7× 76 1.5k

Countries citing papers authored by G. E. Francis

Since Specialization
Citations

This map shows the geographic impact of G. E. Francis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. E. Francis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. E. Francis more than expected).

Fields of papers citing papers by G. E. Francis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. E. Francis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. E. Francis. The network helps show where G. E. Francis may publish in the future.

Co-authorship network of co-authors of G. E. Francis

This figure shows the co-authorship network connecting the top 25 collaborators of G. E. Francis. A scholar is included among the top collaborators of G. E. Francis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. E. Francis. G. E. Francis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Francis, G. E., et al.. (2025). Triage: an academic ‘blind spot’ in Emergency Medicine. Emergency Medicine Journal. emermed–2025.
3.
Yu, Jinxing, et al.. (2020). Clinical features may help to identify children and adolescents with greatest risk for thyroid nodules. Journal of Endocrinological Investigation. 43(7). 925–934. 3 indexed citations
4.
Bianco, Ismael D., et al.. (2002). Coupling Reaction and Properties of Poly(ethylene glycol)-linked Phospholipases A2. Bioscience Biotechnology and Biochemistry. 66(4). 722–729. 5 indexed citations
5.
Francis, G. E. & Cristina Delgado. (2000). Drug targeting : strategies, principles, and applications. Humana Press eBooks. 6 indexed citations
6.
O’Riordan, Catherine R., et al.. (1999). PEGylation of Adenovirus with Retention of Infectivity and Protection from Neutralizing Antibody in Vitro and in Vivo. Human Gene Therapy. 10(8). 1349–1358. 334 indexed citations
7.
Delgado, Cristina, et al.. (1997). Polymer-derivatized Proteins: Analytical and Preparative Problems. Pharmacy and Pharmacology Communications. 3(1). 59–66. 7 indexed citations
8.
Francis, G. E., et al.. (1996). Polyethylene Glycol Modification: Relevance of Improved Methodology to Tumour Targeting. Journal of drug targeting. 3(5). 321–340. 70 indexed citations
9.
Delgado, Cristina, RB Pedley, Ángel Herráez, et al.. (1996). Enhanced tumour specificity of an anti-carcinoembrionic antigen Fab' fragment by poly(ethylene glycol) (PEG) modification. British Journal of Cancer. 73(2). 175–182. 53 indexed citations
10.
Delgado, Cristina, G. E. Francis, & Derek Fisher. (1994). [37] Bioextraction of low abundance cells by affinity partitioning. Methods in enzymology on CD-ROM/Methods in enzymology. 228. 395–402. 1 indexed citations
11.
Delgado, Cristina, et al.. (1994). Quantitative analysis of polyethylene glycol (PEG) in PEG-modified proteins/cytokines by aqueous two-phase systems. Journal of Biochemical and Biophysical Methods. 29(3-4). 237–250. 23 indexed citations
12.
Delgado, Cristina, Manuel Dómine, M. Cristina Tejedor, et al.. (1992). Polyethylene glycol (PEG) modification of granulocyte‐macrophage colony stimulating factor (GM‐CSF) enhances neutrophil priming activity but not colony stimulating activity. British Journal of Haematology. 82(4). 654–663. 30 indexed citations
13.
Francis, G. E., et al.. (1991). Aberrant DNA topoisomerase II activity, radioresistance and inherited susceptibility to cancer. British Journal of Cancer. 63(1). 29–36. 23 indexed citations
14.
Francis, G. E., et al.. (1987). Evidence for the involvement of DNA topoisomerase II in neutrophil-granulocyte differentiation.. PubMed. 1(9). 653–9. 21 indexed citations
15.
Wilson, EL & G. E. Francis. (1987). Differentiation-linked secretion of urokinase and tissue plasminogen activator by normal human hemopoietic cells.. The Journal of Experimental Medicine. 165(6). 1609–1623. 33 indexed citations
16.
Francis, G. E., G J Mufti, S. Knowles, et al.. (1987). Differentiation induction in myelodysplasia and acute myeloid leukaemia: Use of synergistic drug combinations. Leukemia Research. 11(11). 971–977. 17 indexed citations
18.
Francis, G. E.. (1980). A bioassay system for two types of colony stimulating factor in human serum.. PubMed. 8(6). 749–62. 12 indexed citations
19.
Angelini, Paolo, et al.. (1975). Ehlers-Danlos type V (X-linked form): a lysyl oxidase deficiency.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 11(6). 31–37. 5 indexed citations
20.
Francis, G. E., et al.. (1953). A windowless Geiger-Muller counter for 14C and 35S assay in solid samples.. PubMed. 53(3). xxii–xxii. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026